Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Convergence Of Epicardial And Endocardial Radiofrequency (RF) Ablation For The Treatment Of Symptomatic Persistent AF

NCT01984346 is registered in ClinicalTrials.gov with AtriCure, Inc. as lead sponsor.

NCT NCT01984346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01984346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Convergence Of Epicardial And Endocardial Radiofrequency (RF) Ablation For The Treatment Of Symptomatic Persistent AF
Lead sponsor
AtriCure, Inc.
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2013
Completion date
October 31, 2023
Enrollment
170 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

persistent atrial fibrillation